Embla Medical hf. (LON:0FIW)

Market Cap	1.50B -6.5%
Revenue (ttm)	690.02M +8.6%
Net Income	61.92M +22.1%
EPS	0.15 +22.0%
Shares Out	n/a
PE Ratio	24.20
Forward PE	20.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	197
Average Volume	1,158
Open	30.70
Previous Close	n/a
Day's Range	30.70 - 31.15
52-Week Range	27.43 - 36.40
Beta	0.58
RSI	44.64
Earnings Date	Feb 3, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1971
• Employees: 4,195
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0FIW

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD